4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:科研毒素试剂
咨询热线电话
4000-520-616
当前位置: 首页 > 新闻动态 >
新闻详情
Agrenvec/Anti-Human Follistatin (IgG) – RF0060/RF0060/100-microg
来自 : 发布时间:2025-01-16

Description:

 Rabbit Polyclonal Antibody (IgG) to Follistatin

Application:

WB, ELISA

Reactivity:

 Human

Conjugate:

 Unconjugated

ELISA:

 Suggested starting dilution 1/500 anti-rabbit IgG-AP (alkaline phosphatase conjugate) is recommended as secondary reagent.

Description: Anti-Human Follistatin IgG developed in rabbit and purified by affinity chromatography on protein G (> 98% purity).

Immunogen: Highly pure (>97%) recombinant human Follistatin expressed in plants.

Applications:

  • ELISA: Suggested starting dilution 1/500. This antibody, in conjunction with compatible secondary reagent (anti-rabbit IgG-AP conjugate), allows the detection of <10 ng/well of rhuman Follistatin (RF0043).
  • Western Blot: Suggested starting dilution 1/500 anti-rabbit IgG-AP (alkaline phosphatase conjugate) is recommended as secondary reagent.
\"RF0060.-WB-Anti-Human-Follistatin-IgG-202x300\"
Fig 1. Western Blot analysis of rhuman Follistatin using Anti-Human Follistatin IgG (RF0060)
Human Follistatin protein was resolved by SDS-PAGE, transferred to a NC membrane and probed with a dilution 1:1,000 of Anti-Human Follistatin IgG. Anti-rabbit IgG-AP (alkaline phosphatase conjugate) was used as secondary reagent. Lane 1: MWM; Lane 2: 0.25 ug f non glycosylated rHuman Follistatin protein produced in a prokaryotic expression system. Lane 3: 0.25 ug  of glycosylated isoforms of rH Follistatin produced in an eukaryotic expression system.
Where this antibody has not been tested for use in a particular technique this not necessarily excludes its use in such procedures.Optimal dilution conditions should be determined by the final user.Bulk sizes are available upon request. For R&D purposes only.Purchaser must determine the suitability of the product(s) for their particular use.

本文链接: http://list.immuno-online.com/view-1546329322.html

发布于 : 2025-01-16 阅读()